Get the Stockscreener App
10.62
0.05%
0.005
After Hours:
10.62
0.005
+0.05%
Drugs Made In America Acquisition Corp stock is traded at $10.62, with a volume of 524.
It is up +0.05% in the last 24 hours and up +0.14% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.61
Open:
$10.62
24h Volume:
524
Relative Volume:
0.00
Market Cap:
$257.70M
Revenue:
-
Net Income/Loss:
$6.66M
P/E Ratio:
53.56
EPS:
0.1982
Net Cash Flow:
$-379.20K
1W Performance:
+0.05%
1M Performance:
+0.14%
6M Performance:
+2.54%
1Y Performance:
+4.38%
1-Day Range:
$10.62
$10.62
1-Week Range:
$10.60
$10.62
52-Week Range:
$10.17
$10.62
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
646-726-7074
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, EVAC, CEPF
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.62 | 257.58M | 0 | 6.66M | -379.20K | 0.1982 |
LION
Lionsgate Studios Corp
|
14.32 | 4.05B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.77 | 1.98B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
24.43 | 1.23B | 17.25M | -5.64M | -40.16M | -0.3337 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.18 | 593.83M | 0 | 12.80M | -714.00K | 0.2184 |
CEPF
Cantor Equity Partners Iv Inc
|
10.33 | 591.50M | 0 | 10.29M | -337.90K | 0.1801 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
Grove Collaborative (GROV) Edges Higher as Shares Approach Resistance ZoneSMA Signal - newsline.com
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIR - TradingView
GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover - Reuters
Brand Engagement Network Inc. (BNAI) Q3 2025 Earnings: Narrowed Loss Surprises as Pre-Revenue Company Gains MomentumEarnings Growth Forecast - newsline.com
Broadcom, Micron, ARM Lead Chip Stock Decline After Disappointing Broadcom EarningsHigh Estimate Range - newsline.com
Free float of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
QDRO Acquisition Corp.: Performance & Quotes, QADR Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made In America Acquisition II Corp. appoints new CEO after sponsor repayment issue - Investing.com
DeFi Development Corp. Warrant (DFDVW) Testing Support After 3.85% DeclineRatio Spread Trade - thelegaladvocate.com
Shalibhadra Finance Targets Rs 500 Crore AUM on 22% Profit Growth in FY26Net Income Trends - thelegaladvocate.com
C.H. Robinson Tightens Carrier Safety Standards – Supreme Court Ruling May Be a FactorEarnings Decline Risk - newsline.com
Drugs Made In America Acquisition II Corp. Right (DMIIR) Drops 10% as Rights Trade Near Support at $0.08Volatility Breakout Picks - The Legal Advocate
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Steady Amid Extended ConsolidationVolatility Smirk - The Legal Advocate
NXRT Q1 2026 Earnings: Narrower-Than-Expected Loss, Stock Edges LowerBanking Earnings Report - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. Right (DMIIR) Moves Up 8.91% at $0.09 – Right Securities See Renewed InterestGamma Squeeze - The Legal Advocate
Harvard Ave Acquisition (HAVA) Stock Holds Steady at $10.08 as Trading Remains FlatZero Lag EMA - The Legal Advocate
NXGL Q1 2026 Earnings: Larger-Than-Expected Loss Weighs on SharesEarnings Manipulation Risk - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady as SPAC Unit Stabilizes Near SupportRSI Oversold Picks - newsline.com
Evolution Global Acquisition Corp Warrants (EVOXW) Surge 18.6% as Price Approaches Key ResistanceChaikin Flow - The Legal Advocate
Eli Lilly and Company - Britannica
DMIIU Units Edge Lower by 0.44% as Price Holds Near $10.11 Amid Quiet TradingVWAP Breakout - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Steady Near Trust Value Amid Low VolatilityInstitutional Sentiment - The Legal Advocate
DMIIR Rights Hover at $0.09 as Flat Trading Persists for Drugs Made In America Acquisition II Corp.Social Sentiment - The Legal Advocate
Huadi International Group (HUDI) Faces Steep Decline, Testing Key Support at $1.0Turnaround Stocks - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. (DMII) Holds Steady Near Resistance: A Detailed AnalysisAdaptive Moving Average - The Legal Advocate
Drugs Made In America Acquisition Corp. Rights (DMAAR) Edges Higher: Analyzing the $0.12 LevelLiquidity Order Flow - newsline.com
SAGU_u|SAGU_u.NB|Price:10.090|Chg%:0.04 - TradingKey
PTACU|Patriot Acquisition Units (Proposed)|Price:9.950|Chg%:-0.01 - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
MMCAP International Inc. SPC's Drugs Made In America Acquisition II Corp(DMII) Holding History - GuruFocus
Trump-Xi Summit: The 3 Big Takeaways from Historic Meeting in BeijingReturn On Equity - The Legal Advocate
DMAA SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
BofA (BAC) Q1 2026 Earnings: $1.11 EPS Surges Past $1.02 EstimatesAdjusted Earnings Analysis - newsline.com
TradingKey - TradingKey
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition II Corp(DMIIU) Holding History - GuruFocus
Shutterstock, Inc. 8-K Filing: UK CMA Approves Merger with Getty Images Holdings, Inc - Minichart
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
GUACU|Berto Acquisition II Units (Proposed)|Price:10.030|Chg%:-0.01 - TradingKey
DMAA Price Today: Drugs Made In America Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC
Drugs Made In America Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] Drugs Made In America Acquisition Corp. Quarterly Earnings Report - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Drugs Made in America II (DMII) Q1 profit from trust interest amid going-concern risk - Stock Titan
Mizuho Financial Group reports 2,000,000 DMAA shares (DMAA) on 05/14/2026 - Stock Titan
Mercuria Capital Strategies, LLC's Drugs Made In America Acquisition Corp(DMAA) Holding History - GuruFocus
Number of shareholders of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
'Drugs Made In America' SPAC Eyes $1B Deal With AI Platform - Law360
QRED|QuasarEdge Acquisition Units|Price:9.920| - TradingKey
Drugs Made In America Acquisition Corp (DMAA) and Power Analytics Global Corp Announce Definitive $1B AI Merger Agreement - Minichart
Drugs Made In America Acquisition Announces PAGC Merger Deal - TipRanks
Drugs Made In America Acquisition to Merge With Power Analytics Global in Deal Valued Up to $1 Billion - TradingView
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):